SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
73 hedge funds and large institutions have $103M invested in Sierra Oncology, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 29 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+22
Holders Change %
+43.14%
% of All Funds
1.68%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
28
Increased
29
Reduced
3
Closed
6
Calls
–
Puts
$21K
Net Calls
-$21K
Net Calls Change
-$21K
Top Buyers
1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.44M |
2 |
PM
Prosight Management
Dallas,
Texas
|
+$5.26M |
3 |
NLVP
New Leaf Venture Partners
New York
|
+$4.6M |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.62M |
5 |
A
Abingworth
London,
United Kingdom
|
+$2.98M |
Top Sellers
1 |
O
OrbiMed
New York
|
-$2.07M |
2 |
AC
AWH Capital
Dallas,
Texas
|
-$1M |
3 |
EP
Eversept Partners
New York
|
-$250K |
4 |
JG
Jefferies Group
New York
|
-$224K |
5 |
Two Sigma Investments
New York
|
-$178K |